These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3930286)

  • 21. Actions and interactions of ergotamine and dihydroergocristine in rat aortic strips.
    Grana E; D'Agostino G; Zonta F; Lucchelli A
    Farmaco Sci; 1981 May; 36(5):334-43. PubMed ID: 6786918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of prolactin release by prolactin-releasing peptide in rats.
    Matsumoto H; Noguchi J; Horikoshi Y; Kawamata Y; Kitada C; Hinuma S; Onda H; Nishimura O; Fujino M
    Biochem Biophys Res Commun; 1999 Jun; 259(2):321-4. PubMed ID: 10362506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naloxone blocks the effects of delta 9-tetrahydrocannabinol on serum luteinizing hormone and prolactin in rats.
    Kumar MS; Simpkins JW
    Subst Alcohol Actions Misuse; 1983; 4(5):347-53. PubMed ID: 6322367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of naloxone on the suckling induced prolactin release in rats.
    Nagy G; Kacsóh B; Halász B
    Endocrinol Exp; 1982 Nov; 16(3-4):239-46. PubMed ID: 6983432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
    Meltzer HY; Fleming R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats.
    Jones RB; Dickinson K; Anthony DM; Marita AR; Kaul CL; Buckett WR
    Br J Pharmacol; 1997 Mar; 120(6):1135-43. PubMed ID: 9134227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preliminary evaluation of the effect of ibopamine on the secretion of prolactin].
    Scarazzati E; Catenazzo G; Melloni CF; Ghirardi P; Bianco L
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1631-5. PubMed ID: 6667307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin and certain obstetric stress conditions.
    Volpe A; Mazza V; Di Renzo GC
    Int J Biol Res Pregnancy; 1982; 3(4):161-6. PubMed ID: 6818162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of dihydroergocristine on enzyme activities related to energy transduction.
    Gorini A; Villa RF
    Farmaco Prat; 1983 May; 38(5):191-9. PubMed ID: 6409665
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
    Nakagawa T; Ukai K; Ohyama T; Gomita Y; Okamura H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):71-6. PubMed ID: 11062864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydroergotoxine and the Seizure Threshold.
    Pericić D
    Int Pharmacopsychiatry; 1981; 16(1):10-20. PubMed ID: 7298268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ergoloid mesylate dihydroergotoxine: radioimmunoassay measurements on plasma and blood-pressure-lowering activity.
    Woodcock BG; Habedank WD; Loh W; Rietbrock N
    J Cardiovasc Pharmacol; 1984; 6(3):543-5. PubMed ID: 6202984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydroergocristine improves behavioral deficits of aged rats.
    D'Agata V; Spadaro F; Drago F
    Pharmacol Res Commun; 1988 Dec; 20(12):1119-20. PubMed ID: 3145509
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitory effect of dihydroergocristine, phenoxybenzamine and propranolol on the hypermotility induced by low doses of ethyl alcohol in mice.
    Boada JN; Feria M; Serrano M; Darias V
    Arch Farmacol Toxicol; 1979 Aug; 5(2):117-22. PubMed ID: 119498
    [No Abstract]   [Full Text] [Related]  

  • 36. [In vivo antiaggregant activity of dihydroergotoxine].
    Manzanares J; Zaragozá F; Benedí J; Iglesias I
    Arch Farmacol Toxicol; 1986; 12(2-3):139-44. PubMed ID: 3619502
    [No Abstract]   [Full Text] [Related]  

  • 37. Dihydroergocristine. Recent research and development.
    Mailland F
    Arzneimittelforschung; 1992 Nov; 42(11A):1379-80. PubMed ID: 1492856
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dihydroergocristine. Recent research and development].
    Arzneimittelforschung; 1992 Nov; 42(11A):1379-421. PubMed ID: 1492855
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of raubasine and dihydroergocristine on an age-related deficit in passive avoidance learning in rats.
    Chopin P; Briley M
    J Pharm Pharmacol; 1990 May; 42(5):375-6. PubMed ID: 1976794
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of dihydroergocristine infusion on tolbutamide-induced insulin secretion in man.
    Caviezel F; Poli M; Girardi AM; Pozza G
    Experientia; 1979 Oct; 35(10):1402-4. PubMed ID: 115708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.